[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369927-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369927-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-the-hif1a-uca1-ptbp3-axis-a-potential-therapeutic-strategy-for-head-and-neck-cancer","Targeting the HIF1A-UCA1-PTBP3 axis - a potential therapeutic strategy for head and neck cancer","","Long non-coding RNAs drive gene-expression programs in both normal physiology and cancer. In head and neck cancers, especially hypopharyngeal cancer, UCA1 dysregulation correlates with aggressive progression and poor outcomes, yet the underlying mechanism remains unclear. Genetic and animal-model experiments were used to test how HIF1A-dependent, nuclear UCA1 influences migration, invasion, and lymph node metastasis through PTBP3-associated signaling, supported by multiple molecular assays.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-the-hif1a-uca1-ptbp3-axis-a-potential-therapeutic-strategy-for-head-and-neck-cancer/369927/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-the-hif1a-uca1-ptbp3-axis-a-potential-therapeutic-strategy-for-head-and-neck-cancer/369927.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in head and neck cancer?","Question",{"text":63,"@type":64},"The study focuses on hypopharyngeal cancer, where UCA1 upregulation is linked to poor prognosis, but the molecular mechanism regulating tumor progression is not well defined.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers assess the role of UCA1?",{"text":68,"@type":64},"They used genetic silencing and ectopic expression to measure effects on proliferation, colony formation, migration, and invasion in vitro, and then used axenograft animal models to evaluate tumor growth and metastasis.",{"name":70,"@type":61,"acceptedAnswer":71},"What molecular axis is proposed as a therapeutic target?",{"text":72,"@type":64},"The findings suggest an HIF1A-induced nuclear UCA1 mechanism that promotes migration and invasion by interacting with PTBP3, with downstream effects that support lymph node metastasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369927,1790245446,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Sim etal. BMC Cancer (2025) 25:1536 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-15020-z](https://doi.org/10.1186/s12885-025-15020-z)  \nRESEARCH Open Access  \nTargeting the HIF1A-UCA1-PTBP3 axis: a potential therapeutic strategy for head and neck cancer  \nLydia Chin-Ling Sim 1†, Yi-Zih Kuo 1,2†, Tsun-Chih Cheng3†, Chih-Ling Chen 1, Jenn-Ren Hsiao2, Mei-Xuan Ooi 1, Zixi Yun4, Hung-Ying Kao4, Sen-Tien Tsai2,5* and Li-Wha Wu 1,6*  \nAbstract  \nBackground Long non-coding RNAs (lncRNAs) are multifunctional regulators of gene expression and play a vital role in various physiological and pathological processes. The urothelial cancer-associated 1 (UCA1) lncRNA is involved in the development and progression of bladder, colon, stomach, lung, and breast cancers. Pharyngeal cancer, especially those in the hypopharynx (HPC), is a devastating subtype of head and neck cancer often detected in late stages. Although some patients survive under curative treatments, they are still prone to having the disease relapse or metastatic spread. Upregulation of UCA1 expression is associated with disease progression and poor prognosis in HPC patients, but the molecular mechanism by which UCA1 functions in HPC remains unclear.  \nMethods We used genetic silencing and ectopic expression approaches to examine the effect of UCA1 dysregulation on the proliferation, colony formation, migration, and invasion of head and neck cancer cells in vitro. Using axenograft animal model, we employed UCA1-depleted cells to evaluate UCA1’s role in tumor growth and metastasis. RNA pulldown followed by mass spectrometry was used to identify UCA1-interacting proteins. We also examined the downstream effectors and upstream mediator(s) of the UCA1-mediated signaling axis by using RT-qPCR, Western blotting, promoter-driven luciferase, and transendothelial migration assays.  \nResults Ectopic UCA1 expression increased cell migration and invasion but reduced the proliferation of head and neck cancer cells. The increases in migration and invasion are accompanied by elevated levels of epithelial and mesenchymal markers, reminiscent of incomplete epithelial-mesenchymal transition (EMT) . In contrast, depletion of UCA1 had opposite effects. Animal xenograft studies also supported the role of UCA1 in promoting lymph node metastasis. UCA1 was predominantly nuclear localized, where polypyrimidine tract binding protein 3 (PTBP3) binds UCA1 lncRNA. Manipulating PTBP3 expression reversed the effect of UCA1 expression on cell migration and invasion. Moreover, increased UCA1 expression, mimicking the regulatory effect ofTGF-β on cyclin D1, p21, and Smad2  \n†Lydia Chin-Ling Sim, Yi-Zih Kuo and Tsun-Chih Cheng are contributed equally.  \n*Correspondence:  \nSen-Tien Tsai [T602511@mail.ncku.edu.tw](T602511@mail.ncku.edu.tw)[ ](T602511@mail.ncku.edu.tw)Li-Wha Wu [liwhawu@mail.ncku.edu.tw](liwhawu@mail.ncku.edu.tw)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nSim et al. BMC Cancer (2025) 25:1536 Page 2 of 14  \nphosphorylation, could promote trans-endothelial migration. Significan","cbCaisu7BDTxli8h","https://ap.wps.com/l/cbCaisu7BDTxli8h","pdf",7758298,14,"English","# Abstract\n# Introduction\n## Clinical background and challenges in head and neck cancer\n## Hypopharyngeal cancer severity and risk factors\n## Need for biomarkers\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What problem does the study address in head and neck cancer?\",\"answer\":\"The study focuses on hypopharyngeal cancer, where UCA1 upregulation is linked to poor prognosis, but the molecular mechanism regulating tumor progression is not well defined.\"},{\"question\":\"How did the researchers assess the role of UCA1?\",\"answer\":\"They used genetic silencing and ectopic expression to measure effects on proliferation, colony formation, migration, and invasion in vitro, and then used axenograft animal models to evaluate tumor growth and metastasis.\"},{\"question\":\"What molecular axis is proposed as a therapeutic target?\",\"answer\":\"The findings suggest an HIF1A-induced nuclear UCA1 mechanism that promotes migration and invasion by interacting with PTBP3, with downstream effects that support lymph node metastasis.\"}]","Targeting the HIF1A-UCA1-PTBP3 axis - a potential therapeutic strategy for head and neck cancer | PDF",1790185232,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e9954ddaa225bdaf6cf99ae797578b1.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c63b6b2dd32fe7dcdfe3b4a03864ef1.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2433b2a0e52635a35c8f87794e677eaf.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/777eef7f091bd658ea85b4142bb4d8ff.webp",980,1306]